We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TERA:BISTTera Yatirim Menkul Degerler AS Analysis

Data as of 2026-03-12 - not real-time

$0.00

Latest Price

9/10Risk

Risk Level: High

Executive Summary

TeraForce Technology Corporation is grappling with a severe earnings collapse, posting a revenue decline of over 90% and negative operating margins that have pushed profitability deep into the red. Cash reserves are virtually nonexistent while debt towers at nearly $10 million, resulting in a negative book value per share and a return on assets well below zero. The company’s free cash flow is barely positive and operating cash flow remains heavily negative, highlighting a cash‑burn situation that appears unsustainable without external financing. Dividend payments are absent and the balance sheet offers little cushion against further shocks.
On the technical side, the stock trades at an ultra‑low price with an RSI stuck at the maximum, suggesting an overbought condition that contradicts the underlying bearish trend. Volume is stable but extremely thin, and volatility measures are effectively zero, indicating a lack of price movement but also a potential for sudden shifts. The beta is negligible, reflecting minimal correlation with broader market swings, yet the overall risk profile remains high due to liquidity constraints and sector‑specific challenges.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Extreme revenue contraction and negative margins
  • Bearish technical trend despite overbought RSI
  • Thin trading volume and high liquidity risk

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Heavy debt load with negligible equity
  • Lack of cash generation and ongoing cash burn
  • Sector exposure to defense spending uncertainties

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained negative earnings trajectory
  • No dividend or earnings recovery signals
  • Persistent liquidity constraints limiting upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth-91.80%
Profit Margin-128.93%
ROA-58.71%
P/B Ratio-0.0
Op. Cash Flow$-2593000
Free Cash Flow$7.0K
Industry P/E34.6

Technical Analysis

TrendBearish
RSI100.0
Support$0.00
Resistance$0.00
MA 20$0.00
MA 50$0.00
MA 200$0.00
MACDNeutral
VolumeStable
Fear & Greed Index76.59

Valuation

GradeOvervalued
TypeValue

Risk Assessment

00
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.